FDA Investigator

Alan A Rivera, FDA Investigator

Also appears on FDA documents as Alan Rivera, Alan A. Rivera, Rivera, Alan A.

Human DrugsAnimal Drugs & Feeds

FDA inspection record · Last updated August 15, 2026

Overview

  • 40 inspections across 38 sites are on record.
  • 64 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-27.

About Alan Rivera

Alan A Rivera, who also appears on FDA documents as Alan Rivera, is an FDA investigator whose record on Atlas runs from April 2022 to April 2026: 40 inspections at 38 sites and 64 Form 483 observations. Nineteen of the 20 Form 483s in the published record are for human drug facilities; one is for an animal drug manufacturer.

Most of the work is in Puerto Rico. Nine of the 20 Form 483s went to facilities in San Juan, Gurabo, Caguas, Carolina, Juncos, Humacao and Manati, including Amgen Manufacturing in Juncos and Gasco Industrial in Gurabo, which received a 483 in both 2022 and 2023. Five went to Indian facilities, among them Amneal Pharmaceuticals in Palli, Concord Biotech and Stallion Laboratories in Ahmedabad, and OneSource Specialty Pharma in Bengaluru.

The forms are short: 3.2 observations on average, seven at most. The regulation cited most is 21 CFR 211.100(a), written production and process control procedures, followed by 211.192 investigations and 211.22(d) quality unit procedures. Alan Rivera most often inspects with Marian E Ramirez, who co-signed nine of the 20 forms, and Angelica M Hernandez, who co-signed six. For what a 483 is and what follows one, see what an FDA Form 483 is.

At a glance

Inspections

40

Sites

38

Observations

64

Career since

Apr 2022

Form 483s on record

Every Form 483 in the published record that names Alan A Rivera, most recent first.

IssuedCompany and facilityCategoryObservations
7 Oct 2025Materials Characterization Center IncSan Juan, United StatesHuman Drugs1
11 Sep 2025Oxygen Development, L.L.C.Palm Springs, United StatesHuman Drugs3
27 Jun 2025Procter & Gamble Manufacturing Mexico, S. de R.L. de C.V.Naucalpan, MexicoHuman Drugs2
16 May 2025A.I.G Technologies Inc.Deerfield Beach, United StatesHuman Drugs5
28 Mar 2025ONESOURCE SPECIALTY PHARMA LIMITEDBengaluru, IndiaHuman Drugs4
19 Mar 2025Amneal Pharmaceuticals Private LimitedPalli, IndiaHuman Drugs4
17 May 2024V-Ensure Pharma Technologies Pvt LimitedChipley Village, IndiaHuman Drugs2
23 Feb 2024Medipharm Laboratories, IncMiami, United StatesHuman Drugs2
11 Jan 2024Custom Manufacturing CorporationMedley, United StatesAnimal Drugs & Feeds7
8 Dec 2023Gasco Industrial Corp.Gurabo, United StatesHuman Drugs7
23 Oct 2023Omega & Delta Co., Inc.Carolina, United StatesHuman Drugs3
21 Sep 2023Richard E. Colgin, IncDallas, United StatesHuman Drugs5
5 Jul 2023Amgen Manufacturing Limited LLCJuncos, United StatesHuman Drugs3
31 May 2023Auro PR Inc.Caguas, United StatesHuman Drugs2
24 Mar 2023Stallion Laboratories Private LimitedAhmedabad, IndiaHuman Drugs2
17 Mar 2023CONCORD BIOTECH LIMITEDAhmedabad, IndiaHuman Drugs2
20 Jan 2023Galephar Pharmaceutical Research Inc.Humacao, United StatesHuman Drugs2
18 Oct 2022Gasco Industrial Corp.Gurabo, United StatesHuman Drugs5
12 Jul 2022Patheon Puerto Rico, Inc.Manati, United StatesHuman Drugs2
1 Apr 2022NEOLPHARMA, INC.Caguas, United StatesHuman Drugs1

Regulations cited most

How many of Alan A Rivera's Form 483s cite each section of the Code of Federal Regulations.

RegulationWhat it coversForm 483s citing it
21 CFR 211.100(a)Written production and process control procedures4
21 CFR 211.192Production record review and investigation of discrepancies3
21 CFR 211.22(d)Responsibilities of the quality control unit3
21 CFR 211.188(b)(11)Batch production and control records1
21 CFR 211.160(b)Laboratory controls, general requirements1
21 CFR 211.194(a)(4)Laboratory records1
21 CFR 211.113(b)Control of microbiological contamination1
21 CFR 211.42(c)Design and construction of facilities, including aseptic processing areas1

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Amgen Manufacturing Limited LLC27 Apr 2026Human DrugsOn file
Maiva Pharma Private Limited20 Feb 2026Human DrugsOn file
BioMylz Pvt. Ltd.9 Feb 2026Human DrugsOn file
Global Calcium Pvt. Limited3 Feb 2026Human DrugsOn file
Alchymars ICM SM Private Limited4 Dec 2025Human DrugsOn file

Sites inspected

Amgen Manufacturing Limited LLCJuncos, United States1 insp.
Maiva Pharma Private LimitedHosur, India1 insp.
BioMylz Pvt. Ltd.Bengaluru, India1 insp.
Global Calcium Pvt. LimitedHosur, India1 insp.

Co-investigators

Investigators who co-signed a Form 483 with Alan A Rivera.

Full investigator report

Get the verbatim findings behind Alan A Rivera's 64 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

FAQ

Questions about FDA investigator Alan Rivera

Answers drawn from Alan A Rivera's inspection and Form 483 record.

Who is Alan Rivera at the FDA?

Alan A Rivera is an FDA investigator who has conducted 40 inspections at 38 sites since April 2022, almost all of them at human drug manufacturers. The record shows 64 Form 483 observations, with most inspections in Puerto Rico and a smaller set in Florida, Texas, Mexico and India. The most recent inspection on record was in Juncos, Puerto Rico in April 2026.

How many Form 483s has Alan A Rivera issued?

The published record holds 20 Form 483s that name Alan A Rivera, issued between April 2022 and October 2025. They average 3.2 observations each, and the longest carried seven, to Gasco Industrial in Gurabo in December 2023 and Custom Manufacturing Corporation in Medley, Florida in January 2024. Each is listed in the table above.

What does Alan Rivera cite most on Form 483s?

21 CFR 211.100(a), written production and process control procedures, appears on more of Alan Rivera's Form 483s than any other section. 21 CFR 211.192, investigation of discrepancies and failures, and 211.22(d), quality unit procedures, follow. The pattern points to procedures that are not written, not followed, or not investigated when they fail.

Which companies has Alan Rivera inspected?

Companies with a Form 483 from Alan Rivera include Amgen Manufacturing in Juncos, Gasco Industrial in Gurabo, Patheon Puerto Rico in Manati, Amneal Pharmaceuticals in Palli, Concord Biotech in Ahmedabad, OneSource Specialty Pharma in Bengaluru and Procter and Gamble Manufacturing Mexico. The full list, with dates and observation counts, is in the table above.

Who does Alan Rivera inspect with?

The most frequent co-investigator is Marian E Ramirez, who co-signed nine of Alan Rivera's 20 Form 483s. Angelica M Hernandez co-signed six, and Anastasia M Shields and Jose F Velez two each.